WASHINGTON, D.C. Sept 22, 2025 –
In a breaking development, President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. have announced a new health policy advising against the use of Tylenol during pregnancy, citing potential links to autism. The announcement, made public on X by @CollinRugg at 20:57 UTC on September 22, 2025, marks a significant shift in public health guidance and has sparked widespread discussion.
The policy recommendation comes as part of the Trump Administration’s broader Make America Healthy Again (MAHA) initiative, launched to combat the rising tide of childhood chronic diseases. Earlier this month, the MAHA Commission released a strategy with over 120 initiatives aimed at reforming food and health systems, education, and scientific research to protect America’s children. “So taking Tylenol is not good,” President Trump stated during the announcement, emphasizing, “It’s not good. For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary.”
This announcement follows weeks of speculation about the administration’s plans to address acetaminophen’s risks. Shares of Kenvue, the manufacturer of Tylenol, dropped sharply on Monday as investors reacted to the potential policy change. The Washington Post reported that the Trump Administration was set to tie Tylenol to autism risks, with officials also planning to tout leucovorin as a potential treatment for autism, a move billed by the President as “very important.”
However, the policy shift has not been without controversy. Earlier this month, the administration faced criticism for blocking state efforts to expand Medicaid coverage to babies and toddlers, a decision opposed by states like Ohio and Tennessee. Critics argue this move undermines the administration’s stated health priorities for children.
Public discourse on X has also highlighted ongoing debates about vaccines and autism, with some users sharing images comparing CDC immunization schedules from 1986 to 2024 and citing rising autism rates. Despite these concerns, the Centers for Disease Control and Prevention (CDC) reaffirmed on December 30, 2024, that no scientific link has been found between vaccine ingredients and autism spectrum disorder (ASD).
The Trump Administration’s recommendation against Tylenol use during pregnancy represents a bold step in public health policy, but it also underscores the complex and often polarized nature of health debates in America. As the story continues to unfold, the implications for pregnant women, healthcare providers, and pharmaceutical companies remain a focal point of discussion. Stay tuned for further updates.